Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Shift From Loss To Profit

Yahoo FinanceJun 19 11:30 ET

Unusual Options Activity: VLO, GGAL and Others Attract Market Bets, VLO V/OI Ratio Reaches 61.8

EST Jun 14th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend

moomoo NewsJun 14 13:30 ET

Here's How Much $1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 5 years by 4.1% on an annualized basis producing an average annual return of 17.23%. Currently, Alnylam Pharmaceuticals

BenzingaJun 14 13:00 ET

$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 15 years by 1.63% on an annualized basis producing an average annual return of 14.17%. Currently, Alnylam Pharmaceutical

BenzingaJun 13 12:00 ET

Citi's North America Focus List Updated, Adds: Coca-Cola, Evergy, Etc.

Seeking AlphaJun 13 11:02 ET

RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $235

RBC Capital analyst Luca Issi maintains $Alnylam Pharmaceuticals(ALNY.US)$ with a buy rating, and maintains the target price at $235.According to TipRanks data, the analyst has a success rate of 20.3%

moomoo NewsJun 13 06:31 ET · Ratings